Journey Medical Corp reports results for the quarter ended in June - Earnings Summary

Journey Medical

09/08/2022 23:01

* Journey Medical Corp  DERM.OQ  reported a quarterly
adjusted
loss of 43 cents​​ per share for the quarter ended in June. The
mean expectation of three analysts for the quarter was for a
loss of 26 cents per share.
    * Revenue was $18.29 million​; analysts expected $21.31
million. 
    * Journey Medical Corp's reported EPS for the quarter was a
loss
of 43 cents​.
    * The mean earnings estimate of analysts had fallen by
about 14.1%
in the last three months.​ 
    * In the last 30 days one analyst negatively revised an
earnings
estimate 
    * Journey Medical Corp shares had risen by 11.0% this
quarter and
lost 22.9% so far this year.
    * The company reported a quarterly loss of $7.53 million.
    * Wall Street's median 12-month price target for Journey
Medical
Corp is $10.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data August 9
at 10:01 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2022      -0.26          -0.43          Missed
 Mar. 31 2022      -0.31          -0.08          Beat
 Dec. 31 2021      -0.41          -1.64          Missed